Parallel Advisors’s Moderna MRNA Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $125K | Buy |
4,518
+115
| +3% | +$3.17K | ﹤0.01% | 1247 |
|
2025
Q1 | $125K | Buy |
4,403
+451
| +11% | +$12.8K | ﹤0.01% | 1180 |
|
2024
Q4 | $164K | Buy |
3,952
+605
| +18% | +$25.2K | ﹤0.01% | 1009 |
|
2024
Q3 | $224K | Sell |
3,347
-902
| -21% | -$60.3K | 0.01% | 875 |
|
2024
Q2 | $505K | Sell |
4,249
-1,163
| -21% | -$138K | 0.01% | 530 |
|
2024
Q1 | $577K | Buy |
5,412
+1,624
| +43% | +$173K | 0.02% | 493 |
|
2023
Q4 | $377K | Sell |
3,788
-1,922
| -34% | -$191K | 0.01% | 577 |
|
2023
Q3 | $590K | Sell |
5,710
-250
| -4% | -$25.8K | 0.02% | 416 |
|
2023
Q2 | $724K | Sell |
5,960
-508
| -8% | -$61.7K | 0.02% | 378 |
|
2023
Q1 | $993K | Sell |
6,468
-323
| -5% | -$49.6K | 0.03% | 310 |
|
2022
Q4 | $1.22M | Buy |
6,791
+209
| +3% | +$37.5K | 0.05% | 226 |
|
2022
Q3 | $778K | Sell |
6,582
-771
| -10% | -$91.1K | 0.04% | 285 |
|
2022
Q2 | $1.05M | Sell |
7,353
-413
| -5% | -$59K | 0.05% | 237 |
|
2022
Q1 | $1.36M | Buy |
7,766
+399
| +5% | +$69.8K | 0.05% | 221 |
|
2021
Q4 | $1.87M | Buy |
7,367
+1,221
| +20% | +$310K | 0.07% | 182 |
|
2021
Q3 | $2.37M | Buy |
6,146
+2,787
| +83% | +$1.07M | 0.1% | 149 |
|
2021
Q2 | $789K | Buy |
3,359
+67
| +2% | +$15.7K | 0.03% | 292 |
|
2021
Q1 | $431K | Buy |
3,292
+1,703
| +107% | +$223K | 0.02% | 389 |
|
2020
Q4 | $166K | Buy |
1,589
+604
| +61% | +$63.1K | 0.01% | 639 |
|
2020
Q3 | $70K | Buy |
985
+287
| +41% | +$20.4K | ﹤0.01% | 903 |
|
2020
Q2 | $44K | Buy |
698
+52
| +8% | +$3.28K | ﹤0.01% | 1090 |
|
2020
Q1 | $19K | Sell |
646
-1,496
| -70% | -$44K | ﹤0.01% | 1331 |
|
2019
Q4 | $42K | Buy |
2,142
+142
| +7% | +$2.78K | ﹤0.01% | 1090 |
|
2019
Q3 | $32K | Sell |
2,000
-1,200
| -38% | -$19.2K | ﹤0.01% | 1153 |
|
2019
Q2 | $47K | Sell |
3,200
-6,950
| -68% | -$102K | ﹤0.01% | 921 |
|
2019
Q1 | $207K | Buy |
+10,150
| New | +$207K | 0.02% | 388 |
|